Other studies have shown increased activation of cleaved caspase-3 in the hippocampus of AD patients and increases in the levels of synaptic pro-caspase-3 and cleaved caspase-3 in the postsynaptic density fractions [86]. The gene discussed is CASP3; the disease is Alzheimer disease.